NoNO Inc.

5 records totalling $1,972,643.00 CAD, from official Government of Canada open data.

Embed this chart

<iframe src="https://ottawaspends.ca/en/embed/fy/recipient/nono-inc" width="100%" height="360" style="border:0" title="OttawaSpends.ca chart" loading="lazy"></iframe>

By department

National Research Council Canada

$1,972,643

5 records

Records

NoNO Inc. $735,284.00

National Research Council Canada | Conseil national de recherches Canada

Industrial Research Assistance Program – Contributions to Firms

FY 2021-2022

Canada

NoNO Inc. has developed and autoinjector compatible PSD95 inhibitor to provide neuroprotection that can be administered by any caregiver at home, enroute to the hospital or immediately upon arrival in...

NoNO Inc. $515,620.00

National Research Council Canada | Conseil national de recherches Canada

Industrial Research Assistance Program – Contributions to Firms

FY 2018-2019

Canada

This proposal focuses on translating academic discoveries into new treatments for stroke recovery and chronic neurological diseases that constitute massive socioeconomic burdens in Canada and worldwid...

NoNO Inc. $316,576.00

National Research Council Canada | Conseil national de recherches Canada

Industrial Research Assistance Program – Innovation Assistance Program

FY 2020-2021

Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

NoNO Inc. $264,264.00

National Research Council Canada | Conseil national de recherches Canada

Innovation Assistance Program

FY 2020-2021

Canada

The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.

NoNO Inc. $140,899.00

National Research Council Canada | Conseil national de recherches Canada

Industrial Research Assistance Program – Innovation Assistance Program

FY 2020-2021

Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.